development and commercialization of imaging probes

Compsit3 is an early-stage molecular imaging company focused on the development and commercialization of molecular imaging probes for the non-invasive detection of tissue inflammation. Its lead technology is CS-31, an imaging probe that targets and illuminates C3d deposited in tissues, a marker of immune activation, intended as a safer alternative to tissue biopsy for assessing disease activity and therapeutic response to complement inhibitors and other immune modulators.

Read more

companion diagnosticsmolecular imaging